UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049999
Receipt number R000056948
Scientific Title Development of fibroblast sheets aiming for the practical application
Date of disclosure of the study information 2023/01/10
Last modified on 2023/01/10 14:15:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of fibroblast sheets aiming for the practical application

Acronym

Development of fibroblast sheets

Scientific Title

Development of fibroblast sheets aiming for the practical application

Scientific Title:Acronym

Development of fibroblast sheets

Region

Japan


Condition

Condition

wisdom tooth

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To perform functional analysis and safety of fibroblasts and fibroblast sheets established in Clinical Research regarding allogeneic cell bank for regenerative medicine (UMIN000042301)

Basic objectives2

Others

Basic objectives -Others

To explain that fibroblasts may be used in future clinical research of allogenic transplantation and confirm whether consent can be obtained from donors who to participate in "Clinical Research regarding allogeneic cell bank for regenerative medicine (UMIN000042301)" if donors participate in this clinical research

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1. To verify whether fibroblast sheets can be manufactured
2. To confirm whether it is useful to transplant fibroblast sheets in nonclinical studies

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Donors over the age of 20 who participated in "Clinical Research regarding allogeneic cell bank for regenerative medicine (UMIN000042301)" and was able to establish fibroblasts

Key exclusion criteria

none

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Kimikazu
Middle name
Last name Hamano

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science, Graduate School of Medicine

Zip code

7558505

Address

Minami-kogushi 1-1-1, Ube, Yamaguchi

TEL

0836-22-2261

Email

cres-sg1@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Ueno

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science, Graduate School of Medicine

Zip code

7558505

Address

Minami-kogushi 1-1-1, Ube, Yamaguchi

TEL

0836-22-2261

Homepage URL


Email

cres-sg1@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Central Glass Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Institutional Review Board

Address

1-1-1 Minami-Kogushi, Ube, Yamaguchi

Tel

0836-22-2428

Email

clin_res@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 01 Month 10 Day

Date of IRB

2023 Year 01 Month 10 Day

Anticipated trial start date

2023 Year 01 Month 11 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This clinical research is going to perform functional analysis of fibroblasts established in "Clinical Research regarding allogeneic cell bank for regenerative medicine (UMIN000042301)" and nonclinical studies for fibroblast sheets.


Management information

Registered date

2023 Year 01 Month 10 Day

Last modified on

2023 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056948


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name